HIV, VIRAL HEPATITIS AND TUBERCULOSIS PREVENTION - EU CONTRIBUTION TO - EVENT GUIDE - European Commission
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
EU CONTRIBUTION TO
HIV, VIRAL HEPATITIS AND
TUBERCULOSIS PREVENTION
AND INTEGRATED RESPONSE
AIDS 2018
23-27 JULY 2018 • AMSTERDAM • THE NETHERLANDS
EVENT GUIDE
Consumers, Health,
Agriculture and Food
Executive Agency2
SYMPOSIUM OVERVIEW
AIDS 2018 CONFERENCE FROM 23 UNTIL 27 JULY 2018 IN AMSTERDAM,
INCLUDING PRE-EVENTS (STI AND TB 2018)
SATELLITE SESSIONS TITLES ORGANISERS 21 JULY 22 JULY 23 JULY 24 JULY 25 JULY
STI 2018: Understanding International Association of
and addressing the Providers of AIDS Care (IAPAC)
HIV and STI syndemic
pre‑conference: All day All day
• Sialon II project poster,
by Massimo Mirandola,
Verona University Hospital
- CRESP (IT)
TB 2018: Bridging the TB International AIDS Society
and HIV communities (IAS), GGD Amsterdam
pre-conference: and RIVM
• E-DETECT TB project All day
poster, by Gerard Devries,
KNCV (NL)
• TB coalition: Aaron Oxley,
and Timur Abdullaev
Welcome reception Mayor and Alderman
19:00 • 21:30
of the City of Amsterdam
Getting to 90: Addressing ECDC and the European AIDS
12:30 • 14:30
Inequalities in the HIV Clinical Society (EACS)
Emerald
Continuum of Care in Room
Europe and Central Asia
Ministerial policy dialogue WHO Euro and the Ministry
on HIV and related of Foreign Affairs of
comorbidities in eastern the Netherlands 14:00 • 17:30
Europe and central Asia
(EECA)
Harm reduction for people HA-REACT, Chafea, SANTE and
who inject drugs in Europe: EMCDDA 14:45 • 16:45
findings from European Hall 10
Joint Action HA-REACT
European Surveys and ESTICOM, Chafea, SANTE and
Trainings to Improve ECDC 17:00 • 19:00
MSM Community Health Auditorium
(ESTICOM)
‘Leadership Workshop’ Public Health England,
on ‘Eliminating HIV the European AIDS Treatment
transmission is now Group and ECDC 11:00 • 12:30
a reality for gay men: What Atrium 2
has worked and how do (L002)
we replicate our successes
for all?’
Implementing the SDG UNAIDS, IAS, EC
Agenda to leave no one 14:30 • 16:00
behind – Innovations in Hall 12
Europe on the Fast Track
to Ending AIDS symposium
HIV Outcomes workshop HIV Outcomes initiative, EC
on improving long-term 18:30 • 20:00
chronic care for people
living with HIV (PLHIV)
HIV and co-infections in INTEGRATE, Chafea, SANTE
vulnerable populations: and ECDC
Addressing cross-border
treatment needs and 18:30 • 20:30
ensuring earlier diagnosis Forum
of migrants, homeless,
prisoners and other
vulnerable populations
with co- infectionsE U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E 3
2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
(HA-REACT): EU HEALTH PROGRAMME 2014-2020
HARM REDUCTION FOR PEOPLE WHO INJECT DRUGS IN EUROPE:
FINDINGS FROM EUROPEAN JOINT ACTION
MONDAY 23 JULY 2018 ● 14:45 • 16:45 ● HALL 10
CHAIR Mika Salminen, National Institute for Health and Welfare, Finland
CO-CHAIR Jean Luc Sion, European Commission, DG SANTE, Luxembourg
FACILITATOR Sini Pasanen, Civil Society Forum on HIV/AIDS, Hepatitis and Tuberculosis, Finland
14:45 • 14:55 Opening of the Satellite
Mika Salminen, National Institute for Health and Welfare, Finland
Jean Luc Sion, European Commission, DG SANTE, Luxembourg
14:55 • 15:05 EU Policy framework, presenting the Staff Working Document 2018
Jean Luc Sion, European Commission, DG SANTE, Luxembourg
15:05 • 15:15 HIV/HCV testing within low-threshold services for women who use drugs –
barriers and recommendations
Alexandra Gurinova, Deutsche AIDS-Hilfe (DAH), Germany
15:15 • 15:25 Harm reduction services in prisons: gaps, challenges and good practice examples
Heino Stöver, Frankfurt University of Applied Sciences (ISFF), Germany
15:25 • 15:35 Harm reduction services in Europe, Mobile unit service for PWID in Latvia
Luis Sordo Del Castillo, Biomedical Research Networking Centre (CIBER/ISCIII), Spain
15:35 • 15:45 Access barriers and good practices to promote prevention and treatment services for PWID
Jeffrey V. Lazarus, Centre of Excellence for Health, Immunity and Infections (CHIP/REGIONH), Denmark
15:45 • 15:55 Guidance on prevention and control of blood-borne viruses in prison settings
Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
15:55 • 16:45 Round table discussion: What are the challenges for preventing HIV and co-infections
among PWID, what have we learnt from HA‑REACT and other EU actions, and how can
we respond to these challenges? What does integration of services for PWID mean?
PANELISTS J oint Action on integrating prevention, testing and linkage to care strategies across HIV,
FROM viral hepatitis, TB and STIs in Europe (INTEGRATE)
Dorthe Raben, Centre of Excellence for Health, Immunity and Infections (CHIP/REGIONH), Denmark
Early diagnosis and treatment of viral hepatitis (HepCare Europe)
John S. Lambert, UCD/ Mater Misericordiae University Hospital, Ireland
arly detection and integrated management of tuberculosis in Europe (E-DETECT TB)
E
Gerard De Vries, KNCV Tuberculosefonds, Netherlands
European Joint Action on HIV and Co-infection Prevention and Harm Reduction
(HA-REACT)
Aljona Kurbatova, National Institute for Health Development, Estonia
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Dagmar Hedrich, European Monitoring Centre for Drugs and Drug Addiction4
ESTICOM: EUROPEAN SURVEYS AND TRAINING
TO IMPROVE MSM COMMUNITY HEALTH
MONDAY 23 JULY 2018 ● 17:00 • 19:00 ● AUDITORIUM
CHAIR Ulrich Marcus, Robert Koch Institute (RKI), Germany
CO-CHAIR Koen Block, European AIDS Treatment Group (EATG), Belgium
17:00 • 17:08 EU Policy framework, presenting the Staff Working Document 2018
Jean Luc Sion, European Commission, DG SANTE, Luxembourg
17:08 • 17:16 Overview of STI/HIV among MSM in the EU/EEA
Teymur Noori, European Centre for Disease Prevention and Control (ECDC), Sweden
17:16 • 17:24 Drug use among MSM (brief overview with focus on chemsex)
Isabelle Giraudon, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal
17:24 • 17:59 EMIS pan-European MSM survey, Background and overview of study (design, aims and
objectives) – who took part? Focus of the selected results will be on pre-exposure prophylaxis
and chemsex:
a. Distribution of risk and precautionary behaviors
b. Distribution of health promotion needs
c. Prevention intervention performance
d. Sexual morbidities
Axel J. Schmidt, Sigma Research at London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom
Peter Weatherburn, Sigma Research at LSHTM, United Kingdom
17:59 • 18:09 Moderated Q&A session
18:09 • 18:29 ECHOES pan-European MSM Community Health Worker survey
a. Background and overview of study (design, aims and objectives) – who took part?
b. Types of CHW work performed (activities and settings)
c. Motivations and satisfaction about their role as CHW
d. Training received and training needs
Nicolas Lorente, Center for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT), Spain
18:29 • 18:39 Training Programme: Overview of the Training Programme
Barrie Dwyer, Terrence Higgins Trust (THT), United Kingdom
18:39 • 18:49 Initial findings of the Training Programme
a. Training needs of CHWs
b. B
arriers and facilitating factors to performing work as a CHW Experiences and lessons learned from
the Training Programme implementation
Matthias Kuske, Deutsche AIDS-Hilfe (DAH), Germany
18:49 • 18:59 Moderated Q&A sessionE U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E 5
2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
INTEGRATE: HIV AND CO-INFECTIONS IN AT-RISK POPULATIONS: ADDRESSING
CROSS-BORDER TREATMENT NEEDS AND ENSURING EARLIER DIAGNOSIS OF
MIGRANTS, HOMELESS, PRISONERS AND OTHER VULNERABLE POPULATIONS
WITH CO-INFECTIONS
WEDNESDAY 25 JULY 2018 ● 18:30 • 20:30 ● FORUM
CHAIRS John S. Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
Jürgen Rockstroh, University of Bonn, Germany
Daniel Simoes, Grupo de Ativistas em Tratamentos – GAT, Portugal
18:30 • 18:34 Welcome and introduction to the INTEGRATE Joint Action
John S. Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
Lella Cosmaro, Fondazione Lila Milano Onlus, Italy
18:34 • 18:41 EU Policy framework, presenting the Staff Working Document 2018
Jean Luc Sion, European Commission, DG SANTE, Luxembourg
18:41 • 18:48 Monitoring the continuum of care and testing in Europe
Andrew Amato, European Centre for Disease Prevention and Control, Sweden
18:48 • 18:55 Bridging to Eastern Europe and Central Asian countries – opportunities and challenges
Elena Vovc, WHO Regional Office for Europe, Denmark
Session 1: Integrated testing approaches – lessons learned and transferability
across diseases and borders
18:55 • 19:05 .1. HepCare: Lessons learned on HCV testing and treatment among key risk groups, including drug users
1
and homeless, through outreach to the community and integration of primary and secondary care services
John S Lambert, Mater Misericordiae University Hospital and University College Dublin, Ireland
19:05 • 19:15 .2 E-DETECT TB: Find and treat models in The Netherlands and UK, transferability to Eastern Europe
1
(Romania and Bulgaria) and options for integrated care delivery
Gerard de Vries, KNCV Tuberculosis Foundation, Netherlands
19:15 • 19:30 1.3. Questions from the audience and discussion
Session 2: Round table discussion: Risk groups and co-infections:
prevention, linkage to care, and shared care models for care
Jürgen Rockstroh, University of Bonn, Germany
Daniel Simoes, Grupo de Ativistas em Tratamentos – GAT, Portugal
19:30 • 19:45 .1 Short introductory remarks by INTEGRATE partners on:
2
• Transferability of tools on testing and linkage to care across diseases – challenges and opportunities
• How to use data in the implementation of programmes
Dorthe Raben, Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, Denmark
Ann Sullivan, Chelsea and Westminster Hospital NHS Foundation Trust, United Kingdom
Jordi Casabona, Center for Epidemiological Studies on HIV/AIDS in Catalonia (CEEISCAT), Spain
Valerie Delpech, Public Health England (PHE), United Kingdom
19:45 • 20:20 .2 Moderated discussion with panel and audience
2
PANEL MEMBERS
John S. Lambert, Lella Cosmaro, Jean Luc Sion, Andrew Amato, Elena Vovc,
Gerard de Vries, Dorthe Raben, Ann Sullivan, Jordi Casabona, Valerie Delpech
20:20 • 20:30 .3 Conclusions and next steps
2
CHAIRS
John S. Lambert (Mater Misericordiae University Hospital and University College Dublin, Ireland)
Lella Cosmaro (Fondazione Lila Milano Onlus, Italy)6
EXHIBITORS ● STAND 204 – 1
European Commission: Directorate General for Health and Food Safety (DG SANTE); Directorate-General for Research and
Innovation (DG RTD; Consumer, Health and Food Executive Agency (Chafea); European Centre for Disease Prevention and Control
(ECDC); European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
Partners: Health Programme EU networks, HA‑REACT Joint Action; INTEGRATE Joint Action; ESTICOM contract; HEPCARE EUROPE
project; E-DETECT TB project; AIDS Action Europe (AAE); TB Europe Coalition (TBEC) and Correlation network
MEET AND GREET ● STAND 204 – 2
24 JULY 25 JULY 26 JULY 27 JULY
10:00 • 10:30 ECDC/EMCDDA OptTEST ESTICOM
Launch of new ECDC/EMCDDA Legal and regulatory barriers Comunity Health Worker
public health guidance work: Stigma and legal/ training programme
‘Prevention and control of regulatory barriers to provision
blood-borne viruses in prison and uptake of HIV testing
settings’ & treatment services
10:45 • 11:15 OptTEST OptTEST EDCTP ESTICOM
How to increase HIV testing: Legal and regulatory barriers European & Developing Launch of the EMIS/ECHOES
Presentation of tools work: Stigma and legal/ Countries Clinical Trials community project
developed to optimise HIV regulatory barriers to provision Partnership (EDCTP) - Beyond
testing and linkage to care and uptake of HIV testing the trial: an equitable
& treatment services environment for research
11:30 • 12:00 EMCDDA TBEC
The current landscape of Meet TB Europe Coalition!
opioid overdoses and harm
12:15 • 12:45 reduction strategies in Europe ESTICOM ECDC
(presentation) Launch of the EMIS/ECHOES The ECDC HIV Estimates
community reports Accuracy Tool is coming
soon: take a sneak peek at it
13:00 • 13:30 OptTEST INTEGRATE during AIDS 2018 to calculate ESTICOM
How to increase HIV testing: The new results of PARTNER adjusted estimates from case- EMIS results on the topics
Presentation of tools II on condomless anal sex in based HIV surveillance data PrEP and Chemsex
developed to optimise HIV MSM sero‑discordant couples taking into account the issues
testing and linkage to care What are the implications for of missing data and reporting
the treatment as prevention delay. (12:15 • 13:15)
approach and U=U?
13:45 • 14:15 ECDC ECDC ESTICOM
Towards 90-90-90: learn how The ECDC HIV Estimates EMIS results on the topics
to use ECDC’s HIV modelling Accuracy Tool is coming soon: PrEP and Chemsex
tool to estimate national or take a sneak peek at it during
local HIV incidence in our AIDS 2018 to calculate adjusted
‘drop-in’ training estimates from case-based HIV
(13:45 • 14:45) surveillance data taking into
account the issues of missing
data and reporting delay.
(13:30 • 14:30)
14:30 • 15:00 TBEC
Meet TB Europe Coalition!
15:15 • 15:45 HEPCARE EUROPE INTEGRATE AAE
Utilizing a mobile health Reaching key populations in AAE network video: Access
unit to reach vulnerable need of HIV and viral hepatitis to health services for migrants
populations testing and prompt linkage with irregular status
to care through European
16:00 • 16:30 HEPCARE EUROPE Testing Week AAE
Utilizing a mobile health AAE network video: Access
unit to reach vulnerable to health services for migrants
populations with irregular status
16:45 • 17:15 ECDC ESTICOM ESTICOM
Towards 90-90-90: learn how EMIS results on the topics EMIS results on the topics
to use ECDC’s HIV modelling PrEP and Chemsex PrEP and Chemsex
tool to estimate national or
local HIV incidence in our
‘drop‑in’ training
17:30 • 18:00 HEPCARE EUROPE ESTICOM ESTICOM
Utilizing a mobile Comunity Health Worker EMIS results on the topics
health unit to reach training programme PrEP and Chemsex
vulnerable populationsE U C O N T R I B U T I O N T O H I V , V I R A L H E PAT I T I S A N D T U B E R C U LO S I S P R E V E N T I O N A N D I N T E G R AT E D R E S P O N S E 7
2 3 - 2 7 J U LY 2 0 1 8 ● A M S T E R D A M ● T H E N E T H E R L A N D S
EXHIBITION ● STAND 204 – 3
24 JULY 25 JULY 26 JULY 27 JULY
10:00 • 14:00 10:00 • 12:30 10:00 • 14:00 10:00 • 12:00
HEPCARE INTEGRATE MATERIALS RTD HA REACT
14:30 • 18:30 13:00 • 15:30 14:30 • 18:30
ECDC E-DETECT TB ECDC
16:30 • 18:30
EDCTP
GLOBAL VILLAGE ● 23 TO 27 JULY 2018
AIDS Action Europe (AAE) will be implementing in collaboration with the European AIDS Treatment group (EATG) an NGO booth
in the Global Village with a special focus on GO and NGO collaboration in the WHO European region
TB coalition (TBEC) will present two presentations at AIDS Action Europe booth:
TBEC introduction to the network, with specific focus on commonalities: HIV/TB co-infection, transition and integrated health systems
One on transition and sustainability (presenting case studies on Estonia, Bulgaria and Georgia)
Transitioning from donor support for TB and HIV in Eastern Europe: civil society response, Rachael Hore, TBEC/Results UK (UK),
with participation of TBEC members
Correlation network: Harm Reduction Networking Zone
23 July 24 July 25 July 26 July 27 July
The Dutch Drug Policy International Drug New HR challenges Specific target groups Drug User Organisation
Policy and the need for (NPS, Stimulant Use, (Women, Prisoners, and peer involvement
funding Chemsex,...) Migrants, MSM,...) (throughout the whole
programme and Friday)
Drug Consumption
Rooms
New prison guidance at UN/NL-oganised ‘Prison Corner’ inside Harm Reduction Networking Zone, by ECDC/EMCDDA:
Speakers: Anastasia Pharris (ECDC) & Dagmar Hedrich (EMCDDA)
90-minute Panel Discussion with international experts: ‘Connecting the Dots: Stop Overdose Now!’
who will address ‘Global Epidemiology of HIV, HCV, TB and Opioid Overdose: Unrelated Events or Expanded Syndemic?’,
by Stop Overdose Now Foundation (NL) and EMCDDA, speaker Isabelle Giraudon8
When you would like to follow
the European commission activities,
the satellite symposium will take place
in venue: Venue: Hall 10, Auditorium
and Forum
The EC stand exhibition location is 204.
✚ FIND OUT MORE
Directorate-General for Health and Food Safety of the European Commission (DG SANTE)
https://ec.europa.eu/health/communicable_diseases/sexually_transmitted_infections_en
European Centre for Disease Prevention and Control (ECDC)
https://ecdc.europa.eu/en/hiv-infection-and-aids
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
http://www.emcdda.europa.eu/news/2018/ecdc-emcdda-communicable-diseases-prison_en
Consumer, Health, Agriculture and Food Safety Agency (Chafea)
https://webgate.ec.europa.eu/chafea_pdb/health/projects/You can also read
